Physician profile
Brielle Smith
NPI 1043663248
$1,581.87
in general payments reported to CMS, 2019-2025
23 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $256 · 2022: $262 · 2023: $281 · 2024: $388 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $241.34 | 2022-2024 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $169.64 | 2024-2025 | Relexxii |
| Collegium Pharmaceutical, INC. | $151.81 | 2025 | Jornay Pm |
| Corium, LLC | $142.05 | 2022-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $92.88 | 2023-2025 | |
| Adlon Therapeutics L.P. | $82.01 | 2021 | |
| Merck Sharp & Dohme LLC | $77.13 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Supernus Pharmaceuticals, INC. | $71.21 | 2022-2024 | Qelbree |
| Pfizer INC. | $70.99 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.91 | 2021-2025 | |
| Seqirus USA INC | $58.41 | 2025 | Flucelvax |
| Kaleo, INC. | $58.05 | 2022-2024 | Auvi-Q |
| Ultragenyx Pharmaceutical INC. | $57.29 | 2021-2022 | |
| Amphastar Pharmaceuticals, INC. | $43.99 | 2024 | Baqsimi |
| Tris Pharma INC | $41.10 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $31.13 | 2022 | |
| Phadia US INC. | $25.55 | 2023 | Immunocap |
| Glaxosmithkline, LLC. | $21.06 | 2023 | Bexsero |
| Lnhc, INC | $19.41 | 2025 | Zelsuvmi |
| Itf Therapeutics LLC | $19.00 | 2025 | |
| Alk-Abello, INC | $17.98 | 2025 | Neffy |
| Ironwood Pharmaceuticals, INC | $15.30 | 2024 | |
| Cranial Technologies, INC | $14.63 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brielle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.